First-in-Class, First-in-Human Study Evaluating LV305, a Dendritic-Cell Tropic Lentiviral Vector, in Sarcoma and Other Solid Tumors Expressing NY-ESO-1 - Concepedia

Concepedia

Publication | Open Access

First-in-Class, First-in-Human Study Evaluating LV305, a Dendritic-Cell Tropic Lentiviral Vector, in Sarcoma and Other Solid Tumors Expressing NY-ESO-1

DOI Full Paper Access

86

Citations

17

References

2019

Year

Neeta Somaiah, Matthew S. Block, Joseph W. Kim, Geoffrey I. Shapiro, T. Khanh, Patrick Hwu, Joseph P. Eder, Robin L. Jones, Hailing Lu, Jan H. ter Meulen,

Clinical Cancer Research

Abstract

This first-in-class, first-in-human study of LV305 demonstrated a favorable safety profile, induction of antigen-specific responses, and potential clinical activity in patients with advanced cancer.

References

	Year	Citations

Page 1